Advanced search

Combine gene, variant, phenotype, region and year filters

Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.

Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
About your search

IRF7 and COVID-19 are reported together in 4 articles.

Gene

IRF7

HGNC
HGNC:6122
8articles
8mentions
0variants with confirmed gene link
Most co-reported phenotypes (articles)
Phenotype

COVID-19

1,317articles
1,317mentions
12co-reported genes shown
Most co-reported genes (articles)

Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.

Publications

4 records shown · first 60

Whole-Exome Sequencing Reveals Rare Genetic Variants in Saudi COVID-19 Patients with Extreme Phenotypes.

PMID 41012626 | PMCID PMC12474163 | DOI 10.3390/v17091198 · Viruses · 2025 · 17 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIRF7“Moreover, the HLA-B gene exhibited the highest number of rare candidate variants, followed by AK2, IRF7, KMT2D, TAP1, and HLA-DRB1.”0.98hgnc_dict_v1
phenotypeCOVID-19“Whole-Exome Sequencing Reveals Rare Genetic Variants in Saudi COVID-19 Patients with Extreme Phenotypes.”0.98phenotype_alias_lexicon_v2
geneINS“The variants were further categorized by types to include single-nucleotide polymorphisms (SNPs), deletions (DEL), and insertions (INS).”0.98hgnc_dict_v1
geneHLA-DRB1“The gene with the highest number of variants was HLA-DRB1, followed by HLA-B, ABO, HPS4, and SP110 displaying both common polymorphisms and rare variants.”0.98hgnc_dict_v1
TypeEntitySource evidenceConfidenceExtractor
geneIRF7“RESULTS: The study showed that the genetic variants associated with genes such as Homeostatic Iron Regulator (HFE) (found in 7 patients, representing 44%), complement factor H (CFH) (6 patients, 38%), cadherin 23 (CDH23) (4 patients, 25%), cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (3 patients, 19%), Transforming Growth Factor Beta 1 (TGFB1) (3 patients, 19%), CREB-binding protein (CREBBP) (2 patients, 13%), E1A Binding Protein P300 (EP300) (2 patients, 13%), hemoglobin subunit beta (HBB) (2 patients, 13%), interferon regulatory factor 7 (IRF7) (2 patients, 13%), and unc-119 lipid binding chaperone (UNC119) (2 patients, 13%) might be associated with susceptibility to coronavirus.”0.98hgnc_dict_v1
phenotypeCOVID-19“Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.”0.98phenotype_alias_lexicon_v2
geneHFE“Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.”0.98hgnc_dict_v1
geneCFH“RESULTS: The study showed that the genetic variants associated with genes such as Homeostatic Iron Regulator (HFE) (found in 7 patients, representing 44%), complement factor H (CFH) (6 patients, 38%), cadherin 23 (CDH23) (4 patients, 25%), cytotoxic T-lymphocyte associated protein 4 (CTLA-4) (3 patients, 19%), Transforming Growth Factor Beta 1 (TGFB1) (3 patients, 19%), CREB-binding protein (CREBBP) (2 patients, 13%), E1A Binding Protein P300 (EP300) (2 patients, 13%), hemoglobin subunit beta (HBB) (2 patients, 13%), interferon regulatory factor 7 (IRF7) (2 patients, 13%), and unc-119 lipid binding chaperone (UNC119) (2 patients, 13%) might be associated with susceptibility to coronavirus.”0.98hgnc_dict_v1

Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.

PMID 32599245 | PMCID PMC7319641 | DOI 10.1016/j.ijbiomac.2020.06.228 · International journal of biological macromolecules · 2020 · 7 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIRF7“These ISGs (IFIT1, IFITM1, IRF7, ISG15, MX1, and OAS2) can be considered as potential candidates for drug targets in the treatments of COVID-19.”0.98hgnc_dict_v1
phenotypeCOVID-19“Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.”0.98phenotype_alias_lexicon_v2
geneIFIT1“These ISGs (IFIT1, IFITM1, IRF7, ISG15, MX1, and OAS2) can be considered as potential candidates for drug targets in the treatments of COVID-19.”0.98hgnc_dict_v1
geneIFITM1“These ISGs (IFIT1, IFITM1, IRF7, ISG15, MX1, and OAS2) can be considered as potential candidates for drug targets in the treatments of COVID-19.”0.98hgnc_dict_v1

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.

PMID 32972995 | PMCID PMC7857407 | DOI 10.1126/science.abd4570 · Science (New York, N.Y.) · 2020 · 4 validated mentions
TypeEntitySource evidenceConfidenceExtractor
geneIRF7“We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection.”0.98hgnc_dict_v1
phenotypeCOVID-19“Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.”0.98phenotype_alias_lexicon_v2
geneTLR3“We have found an enrichment in rare variants predicted to be loss-of-function (LOF) at the 13 human loci known to govern Toll-like receptor 3 (TLR3)- and interferon regulatory factor 7 (IRF7)-dependent type I interferon (IFN) immunity to influenza virus in 659 patients with life-threatening COVID-19 pneumonia relative to 534 subjects with asymptomatic or benign infection.”0.98hgnc_dict_v1
phenotypeSARS“Clinical outcome upon infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ranges from silent infection to lethal coronavirus disease 2019 (COVID-19).”0.93phenotype_alias_lexicon_v2